The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model.

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Abstract Text:

Hiroaki Ohno,Yasunori Uemura,Hideko Murooka,Hiromi Takanashi,Takemi Tokieda,Yumiko Ohzeki,Kazuo Kubo,Isao Serizawa,Hiroaki Ohno,Yasunori Uemura,Hideko Murooka,Hiromi Takanashi,Takemi Tokieda,Yumiko Ohzeki,Kazuo Kubo,Isao Serizawa,

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Publishing Authors By Initials

H Ohno,Y Uemura,H Murooka,H Takanashi,T Tokieda,Y Ohzeki,K Kubo,I Serizawa,H Ohno,Y Uemura,H Murooka,H Takanashi,T Tokieda,Y Ohzeki,K Kubo,I Serizawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European journal of immunology

VOLUME: 38

Page Numbers: 283-91

Journal Abbreviation:

ISSN: 0014-2980

DAY: 26

MONTH: Jan

YEAR: 2008

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 1273201

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model.

AFFILIATION:

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Immunol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model Related Publications

• A case of splenic inflammatory pseudotumor.
• Biological selection of peptides for poly(l-lactide) substrates.
• Production of functional human selenocysteine-containing KDRF/thioredoxin reductase in E. coli.
• The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model.
• The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis.
• [A case report of giant esophageal leiomyoma associated with an epiphrenic esophageal diverticulum]
• [Counselor's attitude in telephone consultation]
• [Nursing of a patient with loss of spontaneous speech function due to a cerebrovascular disorder]
• [Nursing report: regional public health nursing activities through individual cases]